Sharps Technology Inc. STSS
Institutional shares held
1.16 Million
0
calls
0
puts
Total value of holdings
$243K
$0
calls
$0
puts
Market Cap
$1.93M
9,207,420
Shares Out.
Institutional ownership
12.6%
# of Institutions
9
We take great care to ensure that the data presented and summarized in this overview for Sharps Technology Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding STSS
View all-
Walleye Capital LLC Plymouth, MN887KShares$186,1670.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL121KShares$25,3680.0% of portfolio
-
Compass Ion Advisors, LLC57.1KShares$12,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA41.2KShares$8,6470.0% of portfolio
-
Xtx Topco LTD London, X026.5KShares$5,5660.0% of portfolio
-
State Street Corp Boston, MA21.1KShares$4,4230.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY6.47KShares$1,3580.0% of portfolio
-
Wells Fargo & Company San Francisco, CA91Shares$190.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
Latest Institutional Activity in STSS
Top Purchases
Top Sells
About STSS
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Insider Transactions at STSS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2024
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.44%
|
$0
$0.34 P/Share
|
|
Feb 06
2024
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+10.43%
|
$0
$0.29 P/Share
|
|
Feb 02
2024
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,000
+9.54%
|
$0
$0.35 P/Share
|
|
Jan 31
2024
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,200
+1.61%
|
$0
$0.39 P/Share
|
|
Jan 03
2024
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.47%
|
$0
$0.4 P/Share
|
|
Jan 02
2024
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
4,466
+0.42%
|
$0
$0.4 P/Share
|
|
Dec 22
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.94%
|
$0
$0.4 P/Share
|
|
Nov 22
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
20,000
+0.95%
|
$0
$0.45 P/Share
|
|
Nov 20
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.49%
|
$0
$0.41 P/Share
|
|
Nov 17
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.49%
|
$0
$0.41 P/Share
|
|
Nov 16
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
3,500
+0.17%
|
$0
$0.41 P/Share
|
|
Nov 15
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
2,500
+0.25%
|
$0
$0.41 P/Share
|
|
Apr 14
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+5.74%
|
$4,000
$1.28 P/Share
|
|
Mar 15
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,100
+1.68%
|
$2,100
$1.36 P/Share
|
|
Mar 14
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.65%
|
$1,000
$1.34 P/Share
|
|
Mar 13
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+1.69%
|
$2,000
$1.37 P/Share
|
|
Feb 22
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.88%
|
$500
$1.34 P/Share
|
|
Feb 21
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+0.89%
|
$1,500
$1.35 P/Share
|
|
Feb 17
2023
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+1.36%
|
$1,500
$1.37 P/Share
|
|
Sep 07
2022
|
Robert Michael Hayes Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+2.78%
|
$3,000
$1.34 P/Share
|
Last 12 Months Summary
Buy / Acquisition
90.7K
Shares
From
2
Insiders
| Open market or private purchase | 90.7K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders